NVIDIA
NVDA
Tesla
TSLA
Intel
INTC
Disney
DIS
Micron Technology
MU
US Stock MarketDetailed Quotes
NX Quanex Building Products
- 19.290
- -0.330-1.68%
Close Feb 28 16:00 ET
- 19.540
- +0.250+1.30%
Post 20:01 ET
910.67MMarket Cap21.43P/E (TTM)
19.720High18.990Low571.61KVolume19.690Open19.620Pre Close11.02MTurnover1.36%Turnover Ratio21.43P/E (Static)47.21MShares38.97252wk High0.90P/B811.94MFloat Cap18.99052wk Low0.32Dividend TTM42.09MShs Float38.972Historical High1.66%Div YieldTTM3.72%Amplitude4.257Historical Low19.277Avg Price1Lot Size
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Quanex Building Products Stock Forum
In reaction to earnings/guidance:
• $HashiCorp (HCP.US)$ +16.8%, $Lululemon Athletica (LULU.US)$ +9.7%, $PagerDuty (PD.US)$ +5%, $nCino (NCNO.US)$ +3.8% (also Bank Operating System selected by Rabobank Australia and New Zealand), $Broadcom (AVGO.US)$ +2.1%
Other news:
• $Ooma (OOMA.US)$ +3.5% (acquires Junction Networks also reports earnings)
• $Momentus (MNTS.US)$ +3.5% (files for $200 mln mixed securities shelf offering)
• $Humacyte (HUMA.US)$ +2.9% (fi...
• $Okta (OKTA.US)$ +15.8% (In reaction to earnings)
• $StoneCo (STNE.US)$ +12.9% (In reaction to earnings)
• $Turning Point Therapeutics (TPTX.US)$ +116.8% (Bristol Myers Squibb (BMY) will acquire Turning Point Therapeutics for $76,00 per share; expected to be accretive to Non-GAAP earnings per share beginningin2025)
• $Amylyx Pharmaceuticals (AMLX.US)$ +24.9% (receives PDUFA date extension for AMX0035; scheduled for September ...
No comment yet